ClinicalTrials.Veeva

Menu

a Predictive Scheme for Poor Responders in IVF Cycles

D

Dina Mohamed Refaat Dakhly

Status

Completed

Conditions

Infertility

Treatments

Other: transvaginal Ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT02351193
26012015

Details and patient eligibility

About

While practicing the different assisted reproductive techniques, the investigators are faced daily by the problem of poor responder females, and the debate about predicting its results based on the outcome of the different ORTs used. Due to the cost of AMH as an indicator for ovarian response, the need to re-assess its role was essential in our community, which led us to conduct this prospective multi-center IVF study.

Enrollment

928 patients

Sex

Female

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • normal body mass index (BMI)
  • AMH from 0.5-1.1 ng/ml.
  • previous history of ≤3 oocytes retrieved using conventional long stimulation protocol

Exclusion criteria

  • Females suffering from other causes of infertility as tubal, uterine factors or known cases of endometriosis
  • severe cases of male factor as azospermia
  • females who were unable or not willing to participate in the study were excluded from the study.

Trial design

928 participants in 2 patient groups

Group I
Description:
poor responder females with age less than 35
Treatment:
Other: transvaginal Ultrasound
Group II
Description:
poor responder females with age more than 35
Treatment:
Other: transvaginal Ultrasound

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems